Discussion Room

8 Responses to Discussion Room

  1. debahishsarkar54 says:
    August 10, 2015 at 6:24 am

    Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis ..
    http://www.synthon.com/en/Corporate/News/PressReleases/Pfizer-and-Synthon-Enter-Into-US-Commercialization-Agreement-for-Potential-Generic-Treatment-of-MS.aspx

    Liked by 1 person

    Reply
  2. debahishsarkar54 says:
    August 10, 2015 at 6:34 am

    Lilly’s Tadalafil Particle Size Patent – IPR Granted
    https://www.linkedin.com/grp/post/2101237-6035083447872020484

    Liked by 1 person

    Reply
  3. Nandini says:
    August 14, 2015 at 5:24 pm

    http://www.fda.gov/Drugs/NewsEvents/ucm456973.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
    -USFDA has provided with latest opoids for pediatric pain managment.The article contains discussion about specific Best Pharmaceuticals for Childrens Act(BPCA) which can be informative.

    Liked by 2 people

    Reply

Leave a comment